🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

9 recruiting trials

for Spinal Muscular Atrophy 1

Study of Safety, Tolerability and Efficacy of GB221 in Infants With Spinal Muscular Atrophy Type 1 NCT07070999Phase 1, Phase 21 site📍 Porto Alegre Gemma Biotherapeutics · Tests: GB221 Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology NCT07136844NA1 site📍 Liège Centre Hospitalier Universitaire de Liege · Tests: Syde, Dynamometric measurements of muscle strength, The 6-minute walk test (6MWT), The 10-meter test (10MWT), The 4 sta… Exploring Bulbar Function, Speech And Communication Development in SMA Type 1 NCT05954455n/a1 site📍 London Institute of Child Health UK SMA Patient Registry NCT04292574n/a1 site📍 Newcastle upon Tyne Newcastle University · Tests: Patient Registry Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a2 sites📍 Sioux Falls📍 Sydney Sanford Health Test of Aquatic Mobility of SMA Infants NCT06152302NA1 site📍 Garches Assistance Publique - Hôpitaux de Paris · Tests: Mobility study in dry conditions, Mobility study in water conditions A Phase I/II Clinical Study to Evaluate SKG0201 Injection in Subjects With Spinal Muscular Atrophy Type I NCT07554924Phase 1, Phase 23 sites📍 Beijing📍 Shanghai📍 Hangzhou Lanyue Biotech (Hangzhou) Co., Ltd. · Tests: SKG0201 Injection Evaluation of the Reproducibility of a Fatigability Test Fitted to Patients With Spinal Muscular Atrophy NCT06562283NA4 sites📍 Saint-Etienne📍 Lyon📍 Lyon Centre Hospitalier Universitaire de Saint Etienne · Tests: Thumb test, Grip test, Quadriceps Intermittent Fatigue test (QIF test)) Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 1 Patients NCT05824169Phase 1, Phase 24 sites📍 Beijing📍 Beijing📍 Shenyang GeneCradle Inc · Tests: GC101
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy